[299 Pages Report] The global platelet function test market is expected to be valued at US$ 1178.4 Million in 2022. With the growing prevalence of platelet abnormalities, the overall demand for platelet function tests is projected to grow at a CAGR of 6.3% between 2022 and 2032, totaling around US$ 2170.8 Million by 2032.
| Data Points | Key Statistics |
|---|---|
| Platelet Function Test Market Value 2022 | US$ 1,178.4 Million |
| Platelet Function Test Market Projected Value (2032) | US$ 2,170.8 Million |
| Platelet Function Test Market CAGR (2022 to 2032) | 6.3% |
Platelets are blood cells that are responsible for clotting broken blood arteries. Blood vessels are in charge of transporting blood throughout the body. When blood arteries are injured, platelets link together and clot the affected region, halting blood loss.
The clotting process begins when the injured arteries transmit signals that the platelets pick up on. Platelets go to the wounded location, restructure themselves to create a mesh, and bind to the damaged surface, preventing bleeding. A sufficient quantity of platelets is necessary for the human body for the clotting process to work properly.
In some situations, platelets cease to function effectively and lose their capacity to adhere to the injured region, therefore halting bleeding. These illnesses, which can be inherited or acquired, increase the patient's chance of death. These diseases include ineffective platelet adhesion, platelet aggregation, platelet secretion, pro-coagulant activity, and anomalies in platelet production, hence it is vital to monitor platelet function. Platelet function tests are intended to identify issues related to platelet generation and function in the blood.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global demand for platelet function tests is projected to increase at a CAGR of 6.3% during the forecast period between 2022 and 2032, reaching a total of US$ 2,170.8 Million in 2032, according to a report from Future Market Insights (FMI). From 2017 to 2021, sales witnessed significant growth, registering a CAGR of 6.2%.
A platelet function test is required to determine whether or not a person has a platelet function abnormality. Platelet function is essential for the entire body process. Platelet abnormalities and illnesses can be treated if detected early. As a result, these factors may present strong growth possibilities for the platelet function test market.
Platelet problems such as thrombocytopenia and thrombocythemia are becoming more common, which may raise demand for platelet function tests throughout the projected period. The global elderly population is likewise growing at a rapid pace. As a result, the platelet function test market may see attractive development possibilities as a result of this factor.
Growing Incidence of Platelet Disorders to Accelerate the Market Growth
The platelet function test is in high demand due to the growing incidence of platelet diseases. The rising prevalence of illnesses such as thrombocythemia (an abnormal rise in the number of platelets) and thrombocytopenia (a reduction in the number of platelets) is likely to drive the platelet function test market during the forecast period.
Platelet function abnormalities are 1.5 times more likely to develop in women and the senior population. With the growing worldwide life expectancy rate, there is an expansion in the patient pool requiring platelet function tests, which is predicted to increase demand for the platelet function test market. Because of the growing number of cancer patients, increased use of platelet treatment is likely to drive the platelet function test market.
Other factors such as an increase in surgical operations, more awareness, and the development of new technologies are projected to drive the platelet function test market.
Principal Consultant
Unfavorable Reimbursement Regulations to stymie the Market Growth
Platelet function test market expansion will be hampered by unfavorable reimbursement regulations in emerging nations. In addition, a lack of competent specialists or educated knowledge in developing and undeveloped economies may impede the development rate of the platelet function test market.
Region's Increased Awareness of Platelet-Related Illnesses to Fuel the Market Growth
The platelet function test market in North America is expected to accumulate the highest market share of 29% in 2022. North America has a larger regional share of the global platelet function test market.
North America is likely to lead the platelet function test market during the forecast period, owing to high platelet function test adoption rates and increased awareness of platelet-related illnesses. Furthermore, the existence of various manufacturers, as well as the growing pace of clinical research, is projected to drive platelet function test market expansion in this area.
Massive Patient Population in the Region to Fuel the Market Growth
The Platelet Function Test market in Asia is expected to accumulate a significant market share of 23% in 2022 and is expected to continue to maintain the trend over the forecast period as well.
The Asian market is predicted to have the highest market growth, owing to a massive patient population and manufacturers' development of inexpensive platelet function tests due to low taxation rates. The region's improved distribution channels and huge patient pool are also projected to drive the platelet function test market.
Increased Government Healthcare Spending in the Region to Accelerate Market
The platelet function test market in Europe is expected to accumulate a market share value of 27% in 2022. Europe is predicted to be an important market for platelet function tests, due to increased government healthcare spending and the implementation of efficient reforms for producers of platelet function test kits and systems.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Diagnostics Centers Segment to Drive the Platelet Function Test Market
The platelet function test market is divided into hospitals, blood banks, diagnostics centers, academic institutions, and others based on end-use. The diagnostics centers sector is expected to have the largest market by 2032. A crucial aspect driving this rise is the increasing availability of much user-friendly, portable, and precise testing equipment.
Start-ups and their innovations are driving some of the most recent advances in the platelet function test sector. Let's have a look at some of the primary start-ups in this industry:
F. Hoffmann-La Roche Ltd, Haemonetics Corporation, Siemens AG, Accriva Diagnostics, Helena Laboratories, Terumo BCT, Inc., Fresenius SE & Co KGaA., and Aggredyne, Inc. are some of the main players in the platelet function test industry.
Companies are now concentrating on developing more accurate test methods and analyzers, as well as making ongoing efforts to build distribution channels in growing markets.
Recent Developments:
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 6.3% from 2022 to 2032 |
| Market Value in 2022 | US$ 1,178.4 Million |
| Market Value in 2032 | US$ 2,170.8 Million |
| Base Year for Estimation | 2021 |
| Historical Data | 2017 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in US$ Million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization & Pricing | Available upon Request |
By 2022-end, sales of platelet function test closed at a value of US$ 1178.4 Million
From 2017 to 2021, platelet function test demand expanded at a CAGR of 6.2%
From 2022 to 2032, platelet function test sales are expected to flourish at a CAGR of 6.3%
By 2032, the market value of platelet function test expected to reach US$ 2,170.8 Million
1. Executive Summary | Platelet Function Test Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Platelet Function Test Market Analysis 2016 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ Million) Analysis, 2016 to 2021
4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Platelet Function Test Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2016 to 2021
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2022 to 2032
5.3.1. Systems
5.3.2. Reagents
5.3.3. Accessories
5.4. Y-o-Y Growth Trend Analysis By Product, 2016 to 2021
5.5. Absolute $ Opportunity Analysis By Product, 2022 to 2032
6. Global Platelet Function Test Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2016 to 2021
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2022 to 2032
6.3.1. Hospitals
6.3.2. Blood Banks
6.3.3. Diagnostics Centers
6.3.4. Academic Institutions
6.3.5. Others
6.4. Y-o-Y Growth Trend Analysis By End User, 2016 to 2021
6.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032
7. Global Platelet Function Test Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Application
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Application, 2016 to 2021
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2022 to 2032
7.3.1. Clinical Applications
7.3.2. Research Applications
7.3.3. Pharmaceutical Development
7.3.4. Other Applications
7.4. Y-o-Y Growth Trend Analysis By Application, 2016 to 2021
7.5. Absolute $ Opportunity Analysis By Application, 2022 to 2032
8. Global Platelet Function Test Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2016 to 2021
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. South Asia & Pacific
8.3.5. East Asia
8.3.6. Middle East & Africa (MEA)
8.4. Market Attractiveness Analysis By Region
9. North America Platelet Function Test Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
9.2.1. By Country
9.2.1.1. The US
9.2.1.2. Canada
9.2.2. By Product
9.2.3. By End User
9.2.4. By Application
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By End User
9.3.4. By Application
9.4. Key Takeaways
10. Latin America Platelet Function Test Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product
10.2.3. By End User
10.2.4. By Application
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By End User
10.3.4. By Application
10.4. Key Takeaways
11. Europe Platelet Function Test Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. The UK
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Product
11.2.3. By End User
11.2.4. By Application
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By End User
11.3.4. By Application
11.4. Key Takeaways
12. South Asia & Pacific Platelet Function Test Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Malaysia
12.2.1.3. Singapore
12.2.1.4. Thailand
12.2.1.5. Australia
12.2.1.6. New Zealand
12.2.1.7. Rest of South Asia & Pacific
12.2.2. By Product
12.2.3. By End User
12.2.4. By Application
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By End User
12.3.4. By Application
12.4. Key Takeaways
13. East Asia Platelet Function Test Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Product
13.2.3. By End User
13.2.4. By Application
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By End User
13.3.4. By Application
13.4. Key Takeaways
14. MEA Platelet Function Test Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Product
14.2.3. By End User
14.2.4. By Application
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By End User
14.3.4. By Application
14.4. Key Takeaways
15. Key Countries Platelet Function Test Market Analysis
15.1. The US
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2021
15.1.2.1. By Product
15.1.2.2. By End User
15.1.2.3. By Application
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2021
15.2.2.1. By Product
15.2.2.2. By End User
15.2.2.3. By Application
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2021
15.3.2.1. By Product
15.3.2.2. By End User
15.3.2.3. By Application
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2021
15.4.2.1. By Product
15.4.2.2. By End User
15.4.2.3. By Application
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2021
15.5.2.1. By Product
15.5.2.2. By End User
15.5.2.3. By Application
15.6. The UK
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2021
15.6.2.1. By Product
15.6.2.2. By End User
15.6.2.3. By Application
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2021
15.7.2.1. By Product
15.7.2.2. By End User
15.7.2.3. By Application
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2021
15.8.2.1. By Product
15.8.2.2. By End User
15.8.2.3. By Application
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2021
15.9.2.1. By Product
15.9.2.2. By End User
15.9.2.3. By Application
15.10. India
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2021
15.10.2.1. By Product
15.10.2.2. By End User
15.10.2.3. By Application
15.11. Malaysia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2021
15.11.2.1. By Product
15.11.2.2. By End User
15.11.2.3. By Application
15.12. Singapore
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2021
15.12.2.1. By Product
15.12.2.2. By End User
15.12.2.3. By Application
15.13. Thailand
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2021
15.13.2.1. By Product
15.13.2.2. By End User
15.13.2.3. By Application
15.14. China
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2021
15.14.2.1. By Product
15.14.2.2. By End User
15.14.2.3. By Application
15.15. Japan
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2021
15.15.2.1. By Product
15.15.2.2. By End User
15.15.2.3. By Application
15.16. South Korea
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2021
15.16.2.1. By Product
15.16.2.2. By End User
15.16.2.3. By Application
15.17. Australia
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2021
15.17.2.1. By Product
15.17.2.2. By End User
15.17.2.3. By Application
15.18. New Zealand
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2021
15.18.2.1. By Product
15.18.2.2. By End User
15.18.2.3. By Application
15.19. GCC Countries
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2021
15.19.2.1. By Product
15.19.2.2. By End User
15.19.2.3. By Application
15.20. South Africa
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2021
15.20.2.1. By Product
15.20.2.2. By End User
15.20.2.3. By Application
15.21. Israel
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2021
15.21.2.1. By Product
15.21.2.2. By End User
15.21.2.3. By Application
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Product
16.3.3. By End User
16.3.4. By Application
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. F. Hoffmann-La Roche Ltd
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. Haemonetics Corporation
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. Siemens AG
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. Helena Laboratories
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. Terumo BCT
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. Fresenius SE & Co KGaA
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. Aggredyne, Inc.
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. SENTINEL CH. SpA
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. Drucker Diagnostics
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.10. Thermo Fisher Scientific Inc.
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Explore Healthcare Insights
View Reports
Platelet Function Test Market
